LDLR and atherosclerosis: Hypo-expression of miR-144 in animal models slows down the progression of atherosclerosis [45], and hyperexpression of miR-30c reduces the development of atherosclerosis by inhibiting LDL biogenesis, which was confirmed in mouse models with ApoE-mutants and Ldlr-mutants [46].